Canopus BioPharma Inc. today announces that it has completed crucial research in confirming efficacy of a prescription drug: CB008 for Ebola Virus inhibition.
from The Medical News http://ift.tt/16zZkZG
from The Medical News http://ift.tt/16zZkZG
Our mission is to advice, and to make the people of the world healthier through the power of information.
No comments:
Post a Comment